Genetic risk factors for infection in patients with early rheumatoid arthritis taking etanercept or methotrexate.

被引：0
|
作者：
Hughes, LB
Criswell, LA
Beasley, TM
Edberg, JC
Kimberly, RP
Moreland, LP
Seldin, LF
Bridges, SL
机构：
[1] Univ Alabama, Birmingham, AL USA
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] Univ Calif Davis, Davis, CA 95616 USA
来源：
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S243 / S243
页数：1
相关论文
共 50 条
  • [1] Genetic risk factors for infection in patients with early rheumatoid arthritis
    Hughes, LB
    Criswell, LA
    Beasley, TM
    Edberg, JC
    Kimberly, RP
    Moreland, LW
    Seldin, MF
    Bridges, SL
    GENES AND IMMUNITY, 2004, 5 (08) : 641 - 647
  • [2] Genetic risk factors for infection in patients with early rheumatoid arthritis
    L B Hughes
    L A Criswell
    T M Beasley
    J C Edberg
    R P Kimberly
    L W Moreland
    M F Seldin
    S L Bridges
    Genes & Immunity, 2004, 5 : 641 - 647
  • [3] Risk factors for early complications after orthopedic surgery in rheumatoid arthritis:: The role of methotrexate.
    Cagnoli, M
    Marchesoni, A
    Prudente, P
    Viganò, R
    Tosi, S
    Fantini, F
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S157 - S157
  • [4] A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis
    Bathon, JM
    Martin, RW
    Fleischmann, RM
    Tesser, JR
    Schiff, MH
    Keystone, EC
    Genovese, MC
    Wasko, MC
    Moreland, LW
    Weaver, AL
    Markenson, J
    Finck, BK
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (22): : 1586 - 1593
  • [5] Superior efficacy of etanercept therapy in rheumatoid arthritis when combined with methotrexate.
    Kuhne, C
    Zielinski, S
    Kekow, M
    Kekow, J
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S230 - S230
  • [6] Clinical efficacy and safety of the combination of etanercept plus methotrexate and etanercept alone in the treatment of rheumatoid arthritis patients with an inadequate response to methotrexate. The adore study
    Van Riel, P
    Taggart, A
    Sany, J
    Gaubitz, M
    Lopez, AG
    Korpela, M
    Skjodt, H
    Nab, H
    Pedersen, R
    Freundlich, B
    MacPeek, D
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 437 - +
  • [7] Adverse events in juvenile idiopathic arthritis patients treated with etanercept or the combination of etanercept and methotrexate.
    Southwood, TR
    Cummins, CL
    Foster, HE
    Rahman, JK
    Cotter, KB
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S85 - S86
  • [8] Etanercept and methotrexate in rheumatoid arthritis
    Poteliakhoff, A
    LANCET, 2004, 363 (9422): : 1734 - 1734
  • [9] Infection risk in patients with rheumatoid arthritis treated with etanercept or adalimumab
    Chiang, Yi-Chun
    Kuo, Li-Na
    Yen, Yu-Hsuan
    Tang, Chao-Hsiun
    Chen, Hsiang-Yin
    COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2014, 116 (03) : 319 - 327
  • [10] Macrocytosis is not a predictor of toxicity in patients treated for rheumatoid arthritis with methotrexate.
    Sayers, BS
    ARTHRITIS AND RHEUMATISM, 1996, 39 (06): : R11 - R11
12345